RU2003125096A - PSIMMULATING AGENT - Google Patents
PSIMMULATING AGENT Download PDFInfo
- Publication number
- RU2003125096A RU2003125096A RU2003125096/15A RU2003125096A RU2003125096A RU 2003125096 A RU2003125096 A RU 2003125096A RU 2003125096/15 A RU2003125096/15 A RU 2003125096/15A RU 2003125096 A RU2003125096 A RU 2003125096A RU 2003125096 A RU2003125096 A RU 2003125096A
- Authority
- RU
- Russia
- Prior art keywords
- psychostimulant
- combined
- ladasten
- sydnocarb
- psimmulating
- Prior art date
Links
- 239000003368 psychostimulant agent Substances 0.000 claims 6
- LWJALJDRFBXHKX-UHFFFAOYSA-N bromantane Chemical compound C1=CC(Br)=CC=C1NC1C(C2)CC3CC2CC1C3 LWJALJDRFBXHKX-UHFFFAOYSA-N 0.000 claims 5
- OWFUPROYPKGHMH-UHFFFAOYSA-N n-phenyl-n'-[3-(1-phenylpropan-2-yl)oxadiazol-3-ium-5-yl]carbamimidate Chemical compound C1=C(N=C([O-])NC=2C=CC=CC=2)ON=[N+]1C(C)CC1=CC=CC=C1 OWFUPROYPKGHMH-UHFFFAOYSA-N 0.000 claims 5
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000003670 adamantan-2-yl group Chemical group [H]C1([H])C(C2([H])[H])([H])C([H])([H])C3([H])C([*])([H])C1([H])C([H])([H])C2([H])C3([H])[H] 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2003125096/15A RU2261709C2 (en) | 2003-08-15 | 2003-08-15 | Psychostimulating agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2003125096/15A RU2261709C2 (en) | 2003-08-15 | 2003-08-15 | Psychostimulating agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2003125096A true RU2003125096A (en) | 2005-02-10 |
| RU2261709C2 RU2261709C2 (en) | 2005-10-10 |
Family
ID=35208578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2003125096/15A RU2261709C2 (en) | 2003-08-15 | 2003-08-15 | Psychostimulating agent |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2261709C2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2438677C1 (en) * | 2010-06-30 | 2012-01-10 | Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии Сибирского отделения РАМН | Psychostimulant agent |
| EP4541352A3 (en) * | 2018-07-06 | 2025-07-16 | Algernon Pharmaceuticals Inc. | Compositions and methods for treating non-alcoholic steatohepatitis |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU1746661C (en) * | 1990-06-12 | 1996-01-10 | Научно-исследовательский институт фармакологии РАМН | Salts of n-(2-adamantyl)-n-(3-hydroxypropyl)amine having psychostimulating activity and n-(2-adamantyl)-n-(3-hydroxypropyl)-amine as intermediate compound for synthesis salt of n-(2-adamantyl)-n-hydroxypropyl amine having psychostimulating activity |
| RU2063749C1 (en) * | 1994-02-24 | 1996-07-20 | Михаил Григорьевич Воронков | Medicinal agent showing adaptogenic action |
| RU2196575C2 (en) * | 1999-07-30 | 2003-01-20 | Научно-исследовательский институт фармакологии РАМН | Substance eliciting psychostimulating and antiasthenic effect |
| RU2175229C2 (en) * | 1999-12-22 | 2001-10-27 | Научно-исследовательский институт фармакологии РАМН | Anxiolytic agent |
-
2003
- 2003-08-15 RU RU2003125096/15A patent/RU2261709C2/en active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2261709C2 (en) | 2005-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2025027I1 (en) | Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - extended. | |
| ZA200410109B (en) | Oral pharmaceutical forms of liquid drugs having improved bioavailability. | |
| EA200400664A1 (en) | PHARMACEUTICAL COMPOSITIONS, INCLUDING METHFORMIN AND GLIBENCLAMIDE, APPLIED TO THE TREATMENT OF TYPE II DIABETES | |
| BG106095A (en) | NEW MEDICINAL COMPOSITIONS BASED ON ANTICHLINERGY ACTIVE COMPOUNDS AND BETA-MIMETITIS | |
| DE60024491D1 (en) | FAST-ACTIVE, FREEZER-DRY, ORAL, PHARMACEUTICAL FORMULATION FOR TREATMENT OF MIGRAINE | |
| MXPA02002249A (en) | Palatable pharmaceutical compositions for companion animals. | |
| EP2308479A3 (en) | Compounds and compositions for delivering active agents | |
| CA2294033A1 (en) | Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation | |
| MX2007015480A (en) | Solid dosage formulations of narcotic drugs having improved buccal adsorption. | |
| WO2002030467A3 (en) | Pharmaceutical composition containing honey for the treatment of wounds | |
| NO20041059L (en) | Combination of selected opioids with muscarinic antagonists for the treatment of urinary incontinence | |
| RU2003100507A (en) | PHARMACEUTICAL COMPOSITIONS | |
| SE0102440D0 (en) | New compound | |
| EP1980249A3 (en) | Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser | |
| CA2135179A1 (en) | Pharmaceutical Compositions of Alkylsulphonamides 5HT1 Agonists for Rectal Administration | |
| HUP0203148A2 (en) | Orally distintegrating composition comprising mirtazapine | |
| RU2003125096A (en) | PSIMMULATING AGENT | |
| BE2016C017I2 (en) | ||
| HRP20020989B1 (en) | ENANTIOMER 1,2-ANELIRANOG KINOLINA KOJI INHIBIRA FARNEZIL TRANSFERAZU | |
| RU94040865A (en) | Peptide derivatives and therapeutically acceptable salts thereof, process for preparation thereof, pharmaceutical composition having antiviral activity | |
| MXPA04005033A (en) | Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes. | |
| WO2002004012A8 (en) | Anhydrous pharmaceutical composition of vancomycin for topical use | |
| CA2423288A1 (en) | New pharmaceutical compositions containing epinastine and pseudoephedrine | |
| RU2220131C2 (en) | 4-amino-3-phenylbutanoic acid salts and medicinal agent eliciting anti-ischemic, hypotensive, anti-arrhythmic, nootropic and antihypoxic activity | |
| EP1629845A3 (en) | Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PD4A | Correction of name of patent owner | ||
| PD4A | Correction of name of patent owner |